Novartis Ag (NVS) Total Non-Current Liabilities (2017 - 2025)

Novartis Ag (NVS) has disclosed Total Non-Current Liabilities for 9 consecutive years, with $37.1 billion as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 26.15% to $37.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.1 billion through Dec 2025, up 26.15% year-over-year, with the annual reading at $37.1 billion for FY2025, 26.15% up from the prior year.
  • Total Non-Current Liabilities hit $37.1 billion in Q4 2025 for Novartis Ag, up from $29.4 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $37.1 billion in Q4 2025 to a low of $26.8 billion in Q4 2023.
  • Historically, Total Non-Current Liabilities has averaged $31.3 billion across 5 years, with a median of $29.4 billion in 2024.
  • Biggest five-year swings in Total Non-Current Liabilities: fell 13.0% in 2022 and later grew 26.15% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $33.8 billion in 2021, then dropped by 13.0% to $29.4 billion in 2022, then dropped by 8.75% to $26.8 billion in 2023, then grew by 9.79% to $29.4 billion in 2024, then increased by 26.15% to $37.1 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for NVS at $37.1 billion in Q4 2025, $29.4 billion in Q4 2024, and $26.8 billion in Q4 2023.